Open-label Study to Determine the Maximum Tolerated Dose of MuSK-CAART for MuSK Myasthenia Gravis

Condition:   MuSK Myasthenia Gravis Intervention:   Biological: MuSK-CAART Sponsor:   Cabaletta Bio Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials